Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124937) titled 'The efficacy and safety of High-intensity Focused Ultrasound (HIFU) combined with Serplulimab and Fruquintinib Therapy in Colorectal cancer Liver Metastases' on May 19.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Zhongshan Hospital (Xiamen), Fudan University

Condition: Colorectal cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-01

Target Sample Size: Experimental group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=311997

Disclaimer: Curated by HT Syndication....